NCT00355706

Brief Summary

  1. 1.To demonstrate whether:
  2. 2.To demonstrate whether or not there are clinically significant improvements in function of patients who receive thoracic facet joint nerve block with Depo-steroid compared to patients randomized to Group I who receive only local anesthetic blocks.
  3. 3.To determine the adverse event profile in both groups

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Aug 2003

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2006

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 25, 2006

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

November 26, 2013

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

2.9 years

First QC Date

July 24, 2006

Results QC Date

December 6, 2012

Last Update Submit

March 2, 2020

Conditions

Keywords

chronic low back painthoracic facet jointnerve block

Outcome Measures

Primary Outcomes (2)

  • Numeric Rating Scale

    Numeric rating scale represented 0 with no pain and 10 with the worst pain imaginable.

    2 years

  • Oswestry Disability Index

    Oswestry Disability Index (ODI) - ODI score is ranged from 0 to 50. Total score is converted in to percent disability. ODI Scoring: 0% to 20% (minimal disability), 21%-40% (moderate disability), 41%-60% (severe disability), 61%-80% (crippled) and 81%-100 (these patients are either bed-bound or exaggerating their symptoms).

    24 months

Other Outcomes (1)

  • Opioid Intake

    24 months

Study Arms (2)

Group I - without Steroids

ACTIVE COMPARATOR

Thoracic Facet Joint Nerve Blocks with Local Anesthetic(0.25% Bupivacaine)

Procedure: Thoracic facet joint nerve blocks

Group II - with steroid

ACTIVE COMPARATOR

Thoracic Facet Joint Nerve Blocks with Local Anesthetic (0.25% Bupivacaine) and Sterioids(0.15 mg of non-particulate betamethasone)

Procedure: Thoracic facet joint nerve blocks

Interventions

Thoracic medial branch blocks

Also known as: Thoracic medial branch blocks
Group I - without SteroidsGroup II - with steroid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Positive for facet joint pain with comparative local anesthetic blocks
  • Candidates are over 18 years of age
  • Subjects with a history of chronic, function limiting neck pain of at least six months in duration Subjects who are able to give voluntary, written informed consent to participate in this investigation Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the center for all the required post-operative follow-ups The subject has not had recent surgical procedures within the last three months.

You may not qualify if:

  • Negative or false-positive response to controlled comparative local anesthetic blocks
  • Narcotic use of greater than Hydrocodone 100 mg/day, Methadone 80 mg or Morphine 100 mg, or dose equivalent
  • Uncontrolled major Depression or uncontrolled psychiatric disorders
  • Uncontrolled or acute medical illnesses including coagulopathy, renal insufficiency, chronic liver dysfunction, progressive neurological deficit, urinary sphincter dysfunction, infection, increased intercranial pressure, pseudotumor cerebri, intercranial tumors, unstable angina, and severe chronic obstructive pulmonary disease.
  • Chronic severe conditions that could interfere with the interpretations of the outcome assessments for pain and bodily function
  • Women who are pregnant or lactating
  • Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment
  • Patients with multiple complaints involving concomitant hip osteoarthritis, will not be amenable to study due to the overlap of pain complaints.
  • Inability to achieve appropriate positioning and inability to understand informed consent and protocol History of adverse reaction to local anesthetic or anti-inflammatory drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ambulatory Surgery Center

Paducah, Kentucky, 42003, United States

Location

Related Publications (3)

  • Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V, Fellows B. The role of thoracic medial branch blocks in managing chronic mid and upper back pain: a randomized, double-blind, active-control trial with a 2-year followup. Anesthesiol Res Pract. 2012;2012:585806. doi: 10.1155/2012/585806. Epub 2012 Jul 19.

  • Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year follow-up of thoracic medial branch blocks in management of chronic thoracic pain: a randomized, double-blind active controlled trial. Pain Physician. 2010 Nov-Dec;13(6):535-48.

  • Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: a preliminary report of a randomized, double-blind controlled trial. Pain Physician. 2008 Jul-Aug;11(4):491-504.

Related Links

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Laxmaiah Manchikanti, MD
Organization
Pain Management Center of Paducah

Study Officials

  • Laxmaiah Manchikanti, MD

    Ambulatory Surgery Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

July 24, 2006

First Posted

July 25, 2006

Study Start

August 1, 2003

Primary Completion

July 1, 2006

Study Completion

July 1, 2011

Last Updated

March 10, 2020

Results First Posted

November 26, 2013

Record last verified: 2020-03

Locations